![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Friday, August 05, 2022 4:09:31 PM
PUBLISHER Fintel
PUBLISHED AUG 5, 2022 8:14AM EDT
Following a torrential implosion of market value since February last year, cannabis firm Tilray (US:TLRY, CA:TLRY) finally gave its stakeholders a reason to smile. Management reported encouraging developments for its fiscal year 2022, including double-digit revenue growth and expectations to be cash flow positive in FY 2023. Further, Switzerland legalizing medical marijuana theoretically expands the total addressable market for cannabis companies. Tilray in particular specializes in exploring the therapeutic potential of the plant.
According to the company’s press release, Tilray posted net revenue of $628 million, representing a 22% lift from the prior year’s tally. On a constant currency basis, net sales increased 29% from FY 2021’s result. In the fiscal fourth quarter (ended May 31, 2022), Tilray generated net revenue of $153 million, up 8% from the year-ago level. Adjusted for currency fluctuations, net revenue increased 14% to $163 million.
Additionally, management expects Tilray to generate $70 million to $80 million of adjusted EBITDA (earnings before interest, taxes, depreciation and amortization) and be free cash flow positive in its operating business units in FY 2023.
Following the above disclosure in the early morning of July 28, TLRY stock gained 12% against the prior day’s session. Over the month between July 5 through Aug. 4, shares have swung higher by more than 24%.
Adding to the optimism for TLRY stock and other cannabis players is a Forbes report that Switzerland legalized medical cannabis starting from Aug. 1. As well, new legislation will allow Swiss companies to export medicinal marijuana for commercial purposes.
In September 2018, Tilray garnered major headlines when it announced a partnership with the University of California, San Diego. Under the arrangement, researchers at the University of California School of Medicine conducted a novel clinical trial to “examine the safety, efficacy and pharmacological properties of cannabis as a potential treatment for adults with essential tremor (ET). Currently, ET is treated using repurposed medications originally developed for high blood pressure or seizures. Surgery is another option.”
In its FY 2022 disclosure, Tilray stated that it leads the European medical cannabis sector, with 20% market share in Germany. Irwin D. Simon, Tilray Brands’ chairman and CEO, stated “Over the past year, we have accelerated the optimization of our operations and sharpened execution against our most profitable core business opportunities in medical, adult-use, wellness, and beverage-alcohol across Canada, Europe, and the U.S.”
Although investors have many positive details to chew on, Tilray acknowledged that it suffered a net loss of $457.8 million during fiscal Q4 compared to net income of $33.6 million in the prior-year quarter. To explain this dichotomy, Tilray mentioned challenges including “market conditions inclusive of higher rates of borrowing and lower foreign exchange rates.”
The admission of rising borrowing costs comes amid the consumer price index hitting 9.1% over the year ended June 2022. Also, the purchasing power of the dollar declined by 12.92% from the start of the COVID-19 pandemic through June of this year.
By Joshua Enomoto for Fintel
Recent TLRY News
- Tilray Brands Brews Up Summer Fun for the Fourth of July • GlobeNewswire Inc. • 06/27/2024 12:00:00 PM
- Tilray Brands Announces Runner's High Brewing Company – Its New Brand of Premium Non-Alcoholic Brews • GlobeNewswire Inc. • 06/27/2024 11:04:41 AM
- Celebrate Canada Day with Tilray Brands • GlobeNewswire Inc. • 06/26/2024 11:00:00 AM
- Breckenridge Distillery Releases Award-Winning Collectors Art Series Collaboration With Abby Wren • GlobeNewswire Inc. • 06/25/2024 11:00:00 AM
- Tilray Medical Launches Broken Coast Medical Cannabis Brand in Australia • GlobeNewswire Inc. • 06/20/2024 11:00:00 AM
- Tilray Beverages Announces Campaign to Raise Awareness for Men’s Health • GlobeNewswire Inc. • 06/14/2024 11:00:00 AM
- Embrace the Spirit of Summer and Create Shareable Moments with Good Supply Cannabis • GlobeNewswire Inc. • 06/12/2024 11:00:00 AM
- Breckenridge Distillery Wins Double Gold for a Consecutive Year in a Row at the 2024 New York International Spirits Competition • GlobeNewswire Inc. • 06/06/2024 11:30:00 AM
- Redecan Cannabis Introduces New Top Shelf Flower 'Purple Churro' • GlobeNewswire Inc. • 06/06/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 10:36:34 PM
- Twist Your Tastebuds Three Ways: Good Supply Cannabis Brand Launches ‘Twisted’ All-In-One Vapes • GlobeNewswire Inc. • 05/30/2024 11:00:00 AM
- Solei Brand Introduces New Cannabis-Infused ‘Warming Deep Tissue Stick’ • GlobeNewswire Inc. • 05/23/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 12:00:18 PM
- Tilray Brands Announces At-The-Market Program to Fund Strategic and Accretive Acquisitions and Accelerate Expansion Plan Upon U.S. Cannabis Rescheduling When Effective • GlobeNewswire Inc. • 05/17/2024 11:45:49 AM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/17/2024 11:35:52 AM
- SweetWater Brewing Launches New Sunset Sippin’ Cocktail Inspired Hard Seltzers • GlobeNewswire Inc. • 05/16/2024 11:00:00 AM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/14/2024 08:05:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2024 11:00:34 AM
- Breckenridge Brewery Announces On Tap with KBCO Concert Series Featuring Cannons, The Moss and Dehd • GlobeNewswire Inc. • 05/14/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 11:00:46 AM
- 10 Barrel Brewing Introduces Pub Cerveza: a New Twist on ‘Cheap Fun.’ Series • GlobeNewswire Inc. • 05/03/2024 11:07:37 AM
- Tilray Brands Launches XMG Zero, a New ‘Better for You’ Cannabis Beverage • GlobeNewswire Inc. • 05/02/2024 11:00:00 AM
- Widmer Brothers Brewing Launches New Hefe Variety Pack With Revamped Versions of the Original American Hefeweizen • GlobeNewswire Inc. • 05/01/2024 11:00:00 AM
- Breckenridge Brewery Introduces New West Coast Style IPA ‘Ridge Runner’ • GlobeNewswire Inc. • 04/29/2024 11:00:00 AM
- Tilray Brands Celebrates Big Wins at the Craft Brewer’s Conference and 2024 World Beer Cup, the Most Prestigious Beer Competition in the World • GlobeNewswire Inc. • 04/25/2024 08:33:50 PM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM